OSTEOZOMES
Dead / Abandoned — Abandoned — no statement of use filed (as of 04 Mar 2024)
What this means for you
This application is over — abandoned 04 Mar 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97569410
- Mark type
- Stylized text
- Filed
- 29 Aug 2022
- Published for opposition
- 06 Dec 2022
- Abandoned
- 04 Mar 2024
- Attorney of record
- Amy Rollins
Goods and services
- Class 005 — Pharmaceuticals: Medical products and therapeutic applications for regenerative medicine, cosmetics, and tissue regeneration, namely, human allograft tissue in the form of amniotic patches, amniotic fluid, and purified exosomes, all for the regenerative treatment of wounds, burns, and soft tissue injuries
Owner
- Direct Biologics LLC, Austin, TX, US
- Direct Biologics LLC, St. Louis, MO, US
Prosecution history
- 04 Mar 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 04 Mar 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 16 Jan 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Jan 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 16 Jan 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jun 2023 — SOU EXTENSION 1 GRANTED
- 28 Jun 2023 — SOU EXTENSION 1 FILED
- 28 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 31 Jan 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Dec 2022 — PUBLISHED FOR OPPOSITION
- 16 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Nov 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Oct 2022 — ASSIGNED TO EXAMINER